(Q52179824)

English

Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells.

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

ovarian carcinoma

1 reference

based on heuristic

inferred from title

Frieda Bostick-Bruton

3

object named as

Bostick-Bruton F

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

author name string

Li Q

1

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

Tsang B

2

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

Reed E

4

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

57

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

4

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

347-353

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Mechanisms of DNA excision repair

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

DNA excision-repair synthesis is enhanced in a murine leukemia L1210 cell line resistant to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Different mechanisms are responsible for c-jun mRNA induction by cisplatin and ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Genomic characterization of the human DNA excision repair gene ERCC-1

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Rapid and preferential activation of the c-jun gene during the mammalian UV response

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900291-3

7 January 2021

Identifiers

10.1016/S0006-2952(98)00291-3

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 April 2018

http://europepmc.org/abstract/MED/9933022

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52179824&oldid=1768685774"